molecular formula Cl3Y B085317 Yttrium chloride CAS No. 10361-92-9

Yttrium chloride

Cat. No.: B085317
CAS No.: 10361-92-9
M. Wt: 195.26 g/mol
InChI Key: PCMOZDDGXKIOLL-UHFFFAOYSA-K
Attention: For research use only. Not for human or veterinary use.
In Stock
  • Click on QUICK INQUIRY to receive a quote from our team of experts.
  • With the quality product at a COMPETITIVE price, you can focus more on your research.

Description

Yttrium chloride (YCl₃) is a hygroscopic, water-soluble inorganic compound with the chemical formula Cl₃Y. It commonly exists as a hexahydrate (YCl₃·6H₂O) with a molecular weight of 303.36 g/mol and decomposes at 100°C .

This compound is synthesized via dehydration of the hexahydrate under vacuum or by direct chlorination of yttrium oxide (Y₂O₃) with ammonium chloride . High-purity YCl₃ is critical for metallurgical applications, such as the production of ductile yttrium metal through electrolysis , and serves as a precursor for nanomaterials and medical isotopes (e.g., ⁹⁰Y-labeled compounds for cancer therapy) .

Preparation Methods

Yttrium chloride is often prepared by the “ammonium chloride route,” starting from either yttrium oxide (Y₂O₃) or hydrated chloride or oxychloride . The synthetic route involves the following reactions:

    From Y₂O₃: [ 10 \text{NH}_4\text{Cl} + \text{Y}_2\text{O}_3 \rightarrow 2 (\text{NH}_4)_2[\text{YCl}_5] + 6 \text{NH}_3 + 3 \text{H}_2\text{O} ]

    From YCl₃·6H₂O: [ \text{YCl}_3·6\text{H}_2\text{O} + 2 \text{NH}_4\text{Cl} \rightarrow (\text{NH}_4)_2[\text{YCl}_5] + 6 \text{H}_2\text{O} ]

The pentachloride decomposes thermally to yield this compound(III): [ (\text{NH}_4)_2[\text{YCl}_5] \rightarrow 2 \text{NH}_4\text{Cl} + \text{YCl}_3 ]

Chemical Reactions Analysis

Thermal Decomposition and Stability

Yttrium chloride exhibits distinct thermal behavior:

  • Decomposition temperature : Anhydrous YCl₃ melts at 721°C and boils at 1,507°C .

  • Hydrate decomposition : YCl₃·6H₂O decomposes at 100°C to form YOCl, avoiding reversion to anhydrous YCl₃ .

Property Value Source
Melting point (YCl₃)721°C
Boiling point (YCl₃)1,507°C
YCl₃·6H₂O decompositionYOCl + HCl↑ + H₂O↑

Hydration and Hydrolysis

YCl₃ readily hydrates and hydrolyzes under specific conditions:

  • Hydration : Forms YCl₃·6H₂O, which is highly soluble in water .

  • Hydrolysis : In aqueous solutions, Y³⁺ undergoes hydrolysis, forming complexes like [Y(OH₂)₈]³⁺. At high temperatures (200–500°C), YCl₂⁺ and YCl₃⁰ dominate in chloride-rich hydrothermal fluids .

Key reaction with water :

2Y+6H2O2Y3++6OH+3H22\,\text{Y}+6\,\text{H}_2\text{O}\rightarrow 2\,\text{Y}^{3+}+6\,\text{OH}^-+3\,\text{H}_2\uparrow

Complexation Reactions

This compound forms stable complexes with chloride and organic ligands:

  • Chloro-complexes : In concentrated Cl⁻ solutions, Y³⁺ forms [YCl₆]³⁻ octahedra. Stability constants (logβ) increase with temperature :

Complex 25°C 200°C 350°C 500°C
YCl²⁺0.652.13.85.2
YCl₃⁰4.36.58.9
  • Coordination with THF : YCl₃·3.5THF acts as a catalyst in ring-opening copolymerization (ROCOP) of epoxides and anhydrides .

Reactivity with Acids and Bases

  • Acid reaction : Dissolves in HCl to form Y³⁺ and H₂ gas :

    2Y+6HCl2Y3++6Cl+3H22\,\text{Y}+6\,\text{HCl}\rightarrow 2\,\text{Y}^{3+}+6\,\text{Cl}^-+3\,\text{H}_2\uparrow
  • Base reaction : Reacts with alkoxides to form yttrium alkoxide complexes, precursors for ceramics .

Role in Solid Electrolytes

YCl₃ is critical in synthesizing Li₃YCl₆, a halide solid electrolyte:

  • Intermediate phase : (NH₄)₃[YCl₆] forms during aqueous synthesis, preventing YOCl formation .

  • Phase evolution : Heating YCl₃·6H₂O with LiCl above 200°C yields Li₃YCl₆, which melts at 475°C .

This compound’s reactivity is central to its applications in catalysis, materials science, and geochemistry. Its ability to form stable complexes and intermediates under varied conditions underscores its versatility in both industrial and academic contexts.

Scientific Research Applications

Materials Science

Yttrium Chloride in Ceramics and Superconductors
this compound is crucial in the synthesis of yttrium-based ceramics and superconductors. It serves as a precursor for materials like Yttrium Barium Copper Oxide (YBCO), which is renowned for its high-temperature superconducting properties.

ApplicationDescription
Ceramics Used to create stable and durable ceramic materials, essential for high-performance applications.
Superconductors Facilitates the production of superconducting materials that operate at higher temperatures compared to traditional superconductors.

Phosphor Production

This compound is integral to the manufacturing of phosphors used in light-emitting diode (LED) technologies and display systems. Its ability to enhance brightness and energy efficiency makes it a preferred choice in the electronics industry.

ApplicationDescription
LEDs Enhances brightness and energy efficiency in LED lights.
Display Technologies Key ingredient in phosphors for televisions and monitors, improving color quality.

Catalysis

In organic synthesis, this compound acts as a catalyst to improve reaction rates and selectivity. Its application in catalysis is vital for developing more efficient chemical processes.

ApplicationDescription
Catalysis Used to facilitate various chemical reactions, enhancing efficiency and selectivity in organic synthesis.

Biomedical Applications

This compound has emerging applications in biomedicine, particularly in targeted drug delivery systems and as a contrast agent in medical imaging. Its unique properties allow for clearer imaging results, which are crucial for diagnostics.

ApplicationDescription
Drug Delivery Potential use in targeted therapies to improve drug efficacy while minimizing side effects.
Medical Imaging Serves as a contrast agent in imaging techniques like MRI, enhancing image clarity.

Nuclear Medicine

Yttrium-90 chloride, a radioisotope derived from this compound, plays a critical role in radioimmunotherapy for cancer treatment. It allows for targeted radiation therapy that minimizes damage to surrounding healthy tissues.

ApplicationDescription
Radioimmunotherapy Utilized to deliver targeted radiation to cancer cells while sparing healthy tissues.
Radioembolization Used in treating liver cancer by delivering radiation directly to tumors through blood vessels.

Case Study 1: this compound in Superconductors

Research has demonstrated that YBCO synthesized using this compound exhibits superior performance at elevated temperatures compared to traditional superconductors. This advancement has implications for power grids and magnetic resonance imaging technologies .

Case Study 2: Cytotoxicity Studies

A study investigating the cytotoxic effects of this compound on cardiomyocytes revealed that exposure can lead to DNA damage via reactive oxygen species overproduction . This finding underscores the importance of understanding the biological impacts of yttrium compounds as they are increasingly used in medical applications.

Mechanism of Action

The mechanism of action of yttrium chloride(III) varies depending on its application. In biological systems, yttrium ions (Y³⁺) are taken up by phagocytic cells in the liver and spleen, where they can cause acute hepatic injury and increase plasma calcium levels . In materials science, this compound(III) acts as a precursor for the synthesis of yttrium-based materials, where it undergoes various chemical reactions to form the desired products.

Comparison with Similar Compounds

Structural and Crystallographic Comparison

Compound Coordination Geometry Dimerization in Molten State Key Structural Features Reference
Yttrium chloride Octahedral No Layered structure; strong Y–Y bonding
Aluminium chloride Tetrahedral (Al₂Cl₆) Yes Dimeric form dominates below 200°C
Lanthanum chloride Hexagonal close-packed No La³⁺ ions in 9-coordinate geometry

This compound exhibits reduced halide phases (e.g., YCl and YCl₁.₅) with metal-metal bonding, a feature absent in most transition metal chlorides . In contrast, lanthanum chloride (LaCl₃) adopts a 9-coordinate structure, reflecting the larger ionic radius of La³⁺ compared to Y³⁺ .

Solubility in Non-Aqueous Solvents

Data from Solubility Data Series ():

Compound Solubility in Ethanol (g/100g, 25°C) Solubility in Acetone (g/100g, 25°C)
This compound 15.2 Insoluble
Scandium chloride 22.5 8.7
Lanthanum chloride 9.8 Insoluble

This compound shows moderate solubility in polar solvents like ethanol but is insoluble in acetone, contrasting with scandium chloride (ScCl₃), which exhibits higher solubility due to smaller ionic size and stronger Lewis acidity .

Thermal Stability and Melting Points

Compound Melting Point/Decomposition (°C) Thermal Behavior
YCl₃·6H₂O 100 (decomposition) Releases water and HCl upon heating
AlCl₃ 192 (sublimation) Sublimes without melting
LaCl₃ 858 Stable up to 800°C in inert atmospheres

Anhydrous YCl₃ is thermally stable but highly hygroscopic, requiring vacuum distillation for purification . In contrast, LaCl₃ has a higher melting point, reflecting stronger ionic bonding due to the larger La³⁺ ion .

Research Findings and Challenges

  • Toxicity : YCl₃ administration in rats alters hepatic Ca²⁺ and K⁺ levels and increases liver enzymes (AST/ALT) at doses >1 mg/kg, suggesting dose-dependent hepatotoxicity .
  • Purification Challenges : Residual oxychlorides (YClO) in YCl₃ complicate metal production, necessitating vacuum distillation .

Biological Activity

Yttrium chloride (YCl₃) is a compound of yttrium, a rare earth element, that has garnered attention for its biological activity, particularly its effects on cellular processes and potential applications in medical treatments. This article synthesizes findings from various studies to provide a comprehensive overview of the biological activity of this compound, including its mechanisms of action, cytotoxicity, and implications for health.

Recent research has highlighted the cytotoxic effects of YCl₃ on various cell types. A significant study demonstrated that long-term exposure to YCl₃ induces apoptosis in Leydig cells, which are crucial for testosterone production in the testes. The mechanism involves the upregulation of the Ca²⁺/IP₃R₁/CaMKII signaling pathway, leading to increased intracellular calcium levels and activation of apoptotic pathways .

Key Findings:

  • Cell Apoptosis : YCl₃ treatment resulted in increased expression of cleaved caspase-3 and decreased Bcl-2 levels, indicating a shift towards apoptosis in Leydig cells .
  • Calcium Signaling : The compound enhances cytosolic Ca²⁺ concentrations, which is crucial for activating apoptotic signals .

Cytotoxicity Studies

This compound's cytotoxicity has been evaluated in various models, revealing significant effects on cell viability:

Study Cell Type IC₅₀ (µM) Effects Observed
Leydig Cells300Induction of apoptosis
MDA-MB-231 (Breast Cancer)74.4Selective cytotoxicity through ROS generation

In a study focusing on breast cancer cells (MDA-MB-231), YCl₃ exhibited selective cytotoxic effects, primarily through the generation of reactive oxygen species (ROS), leading to DNA damage and apoptosis .

Case Studies

  • Reproductive Toxicity : In an animal model, chronic exposure to YCl₃ resulted in significant testicular damage characterized by cellular apoptosis and alterations in hormone production. This was associated with upregulation of apoptotic markers and disruption of normal Leydig cell function .
  • Hepatic Effects : Another study noted that intravenous administration of YCl₃ led to accumulation in the liver and spleen, causing transient increases in liver enzymes (AST and ALT), indicative of hepatic stress . The compound was found to form colloidal materials within phagocytic cells, impacting calcium metabolism significantly.

Implications for Medical Applications

This compound has been explored for its potential therapeutic applications, particularly in targeted therapies such as radioisotope treatment for cancer. The ability to accumulate selectively in certain tissues suggests that it could be utilized for localized treatment strategies while minimizing systemic toxicity.

Potential Applications:

  • Cancer Treatment : Leveraging its cytotoxic properties against cancer cells while minimizing damage to normal tissues.
  • Radiopharmaceuticals : As a carrier for radioactive isotopes, enhancing the efficacy of radiotherapy through targeted delivery.

Q & A

Basic Research Questions

Q. What are the standard methods for synthesizing yttrium hydroxide (Y(OH)₃) from yttrium chloride, and how is purity ensured?

  • Methodology : Add 0.1 M NaOH solution incrementally to a 0.1 M YCl₃ solution until pH ~10.1 to precipitate Y(OH)₃. The precipitate is washed with redistilled water until filtrate conductivity stabilizes (~20 μS), ensuring removal of NaCl byproducts .
  • Key Metrics : Monitor pH adjustments and conductivity to confirm chloride ion removal. Use X-ray diffraction (XRD) to verify crystallinity and inductively coupled plasma (ICP) spectroscopy for elemental purity.

Q. How can yttrium citrate complexes be synthesized from YCl₃, and what factors influence hydration states?

  • Methodology : React YCl₃ with trisodium citrate in a 1:1 molar ratio under pH 7–7. Hydration states (1–3 H₂O molecules) vary with reaction duration, temperature, and drying conditions .
  • Validation : Thermogravimetric analysis (TGA) quantifies water content, while infrared (IR) spectroscopy confirms citrate coordination.

Q. What safety protocols are critical when handling anhydrous YCl₃ in laboratory settings?

  • Guidelines : Use fume hoods for powder handling (risk of respiratory irritation). Store in airtight containers to prevent hydrolysis. Anhydrous YCl₃ (99.99% purity) requires gloveboxes for moisture-sensitive reactions .

Advanced Research Questions

Q. How does YCl₃ doping influence the magnetic properties of Fe₃O₄ nanoparticles?

  • Experimental Design : Electrosynthesize Y³⁺-doped Fe₃O₄ nanoparticles using YCl₃·7H₂O and Fe precursors. Vary Y³⁺ concentrations (0.1–5 mol%) and characterize via vibrating sample magnetometry (VSM) and Mössbauer spectroscopy .
  • Data Interpretation : Higher Y³⁺ doping reduces saturation magnetization due to lattice distortion but enhances thermal stability.

Q. What discrepancies exist in reported hydration states of yttrium citrate, and how can they be resolved?

  • Contradiction Analysis : Literature reports 1–3 H₂O molecules in yttrium citrate, influenced by synthesis pH (7 vs. 8) and citrate counterion ratios. Controlled studies using isothermal TGA and dynamic vapor sorption (DVS) can isolate humidity effects .

Q. What advanced techniques validate the purity of YCl₃ precursors for high-performance materials?

  • Analytical Workflow :

ICP-MS for trace metal analysis (e.g., Fe, Ca impurities).

Karl Fischer titration for moisture content in anhydrous YCl₃.

Synchrotron XRD to detect amorphous impurities in nanoscale YCl₃-derived oxides .

Q. Methodological Considerations

Q. How can researchers optimize YCl₃-based precursor solutions for thin-film deposition?

  • Optimization Steps :

  • Solvent selection: Use ethanol/water mixtures to balance solubility and evaporation rates.
  • Additives: Citric acid (1–2 wt%) improves film homogeneity by chelating Y³⁺ ions.
  • Spin-coating parameters: 2000–3000 rpm for 30 sec yields uniform layers; anneal at 400°C in Ar to prevent oxidation .

Q. What are the limitations of using YCl₃ in biomedical studies, and how are they mitigated?

  • Challenges : Hydrolysis in aqueous media forms colloidal Y(OH)₃, complicating biodistribution studies.
  • Solutions : Stabilize YCl₃ with polyvinylpyrrolidone (PVP) or encapsulate in liposomes. Validate cytotoxicity via MTT assays on HEK293 cells .

Q. Data Presentation Guidelines

  • Tables : Include synthesis parameters (pH, molar ratios) and characterization data (e.g., TGA weight loss percentages).
  • Figures : XRD patterns comparing hydrated vs. anhydrous phases; VSM plots for doped nanoparticles.
  • Reproducibility : Document batch-to-batch variability in supplementary materials (e.g., ±2% in Y³⁺ doping efficiency) .

Properties

CAS No.

10361-92-9

Molecular Formula

Cl3Y

Molecular Weight

195.26 g/mol

IUPAC Name

trichloroyttrium

InChI

InChI=1S/3ClH.Y/h3*1H;/q;;;+3/p-3

InChI Key

PCMOZDDGXKIOLL-UHFFFAOYSA-K

SMILES

[Cl-].[Cl-].[Cl-].[Y+3]

Canonical SMILES

Cl[Y](Cl)Cl

Key on ui other cas no.

10361-92-9

physical_description

WetSolid

Related CAS

10025-94-2 (hexahydrate)

Synonyms

YCl3
yttrium chloride
yttrium chloride hexahydrate
yttrium chloride, (88)Y-labeled
yttrium chloride, (90)Y-labeled
yttrium chloride, (91)Y-labeled

Origin of Product

United States

Disclaimer and Information on In-Vitro Research Products

Please be aware that all articles and product information presented on BenchChem are intended solely for informational purposes. The products available for purchase on BenchChem are specifically designed for in-vitro studies, which are conducted outside of living organisms. In-vitro studies, derived from the Latin term "in glass," involve experiments performed in controlled laboratory settings using cells or tissues. It is important to note that these products are not categorized as medicines or drugs, and they have not received approval from the FDA for the prevention, treatment, or cure of any medical condition, ailment, or disease. We must emphasize that any form of bodily introduction of these products into humans or animals is strictly prohibited by law. It is essential to adhere to these guidelines to ensure compliance with legal and ethical standards in research and experimentation.